Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Venlafaxine for major depression.

Literature DB >> 17272528

Venlafaxine for major depression.

Andrea Cipriani, John R Geddes, Corrado Barbui.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2007 PMID： 17272528 PMCID： PMC1790758 DOI： 10.1136/bmj.39098.457720.BE

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

16 in total

1. Suicide, depression, and antidepressants.

Authors: Andrea Cipriani; Corrado Barbui; John R Geddes
Journal: BMJ Date: 2005-02-19

Review 2. Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials.

Authors: Dean Fergusson; Steve Doucette; Kathleen Cranley Glass; Stan Shapiro; David Healy; Paul Hebert; Brian Hutton
Journal: BMJ Date: 2005-02-19

3. Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study.

Authors: Carlos Martinez; Stephan Rietbrock; Lesley Wise; Deborah Ashby; Jonathan Chick; Jane Moseley; Stephen Evans; David Gunnell
Journal: BMJ Date: 2005-02-19

4. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review.

Authors: David Gunnell; Julia Saperia; Deborah Ashby
Journal: BMJ Date: 2005-02-19

5. Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis.

Authors: Gerald Gartlehner; Richard A Hansen; Timothy S Carey; Kathleen N Lohr; Bradley N Gaynes; Leah C Randolph
Journal: Int Clin Psychopharmacol Date: 2005-03 Impact factor: 1.659

Review 6. Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis.

Authors: David Smith; Carrie Dempster; Julie Glanville; Nick Freemantle; Ian Anderson
Journal: Br J Psychiatry Date: 2002-05 Impact factor: 9.319

Venlafaxine for major depression.

1. Suicide, depression, and antidepressants.

Review 2. Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials.

3. Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study.

4. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review.

5. Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis.

Review 6. Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis.

Review 7. Depression, antidepressants and suicidality: a critical appraisal.

8. Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study.

9. Antidepressants and the risk of suicidal behaviors.

10. Antidepressants and suicide.

1. Suicidal and self harming behaviours may be distinct.

2. Developing primary care treatment of depression.

3. Re-evaluation of the efficacy and tolerability of venlafaxine vs SSRI: meta-analysis.

Review 4. Sertraline versus other antidepressive agents for depression.

Review 5. Depression in adults: drug and physical treatments.

Review 6. Citalopram versus other anti-depressive agents for depression.

Review 7. Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies.

Review 8. Depression in adults: drug and physical treatments.

Review 9. Antidepressants and Suicide Risk: A Comprehensive Overview.